Frontlight ResearchEarly access
HIV trials in United States
365 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United StatesBaricitinib Curative Repression of HIV-1
- Where
- Atlanta
- Age
- 18 years to 70 years
- People
- 35
- Run by
- Emory University
See details and how to joinNCT07209267 - No phaseTaking peopleOlfactory Function and Model-Based Behavior in People Living With HIV and SUD
- Where
- Baltimore
- Age
- 18 years to 65 years
- People
- 120
- Run by
- National Institute on Drug Abuse (NIDA)
See details and how to joinNCT07637669 - No phaseTaking peopleClinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
- Where
- Bethesda
- Age
- 18 years and over
- People
- 600
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00789009 - Phase 4Taking peopleUsing Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
- Where
- New York
- Age
- 18 years and over
- People
- 500
- Run by
- New York University
See details and how to joinNCT06598397 - Phase 2Taking peopleA Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- Where
- Albany, Atlanta, Aurora, Bakersfield, Bellaire, Charlotte, Chicago, Cincinnati, Columbia, Dallas, Durham, Ft. Pierce, Greensboro, Hackensack, Hollywood, Houston, Kansas City, Longview, Louisville, Macon, Manhasset, Miami, Miami Gardens, Newark, New Haven, Oakland Park, Omaha, Orlando, Palm Springs, Seattle, West Hollywood, West Palm Beach, Wilmington
- Age
- 18 years and over
- People
- 186 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00 - No phaseTaking peopleLinking Youth to Pre-Exposure Prophylaxis (PrEP) Services
- Where
- Atlanta, Baltimore, Houston, San Francisco
- Age
- 13 years to 24 years
- People
- 272
- Run by
- Westat
See details and how to joinNCT07438041 - Phase 1Taking peopleA Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
- Where
- Atlanta, Birmingham, Boston, Decatur, Houston, New York, Philadelphia, Rochester, Seattle
- Age
- 18 years to 60 years
- People
- 42 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07569029 - Phase 2Taking peopleA Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)
- Where
- Boston, Philadelphia, San Francisco, Washington D.C.
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07850609 - Phase 2Not yet taking people in United StatesA Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size
- Where
- Atlanta, Aurora, Birmingham, Boston, Chapel Hill, Chicago, Cincinnati, Cleveland, Columbus, Houston, Los Angeles, Nashville, New York, Philadelphia, Pittsburgh, Rochester, San Diego, San Francisco, Seattle, Washington D.C.
- Age
- 18 years to 70 years
- People
- 45
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07881809 - Phase 1/2Not yet taking people in United StatesLM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment
- Where
- Chapel Hill
- Age
- 50 years to 75 years
- People
- 68
- Run by
- University of North Carolina, Chapel Hill
See details and how to joinNCT07934186 - No phaseTaking peopleLeukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 750
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT00039689 - Phase 2Taking peopleImaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 50
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05419024 - No phaseTaking peopleMindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIV
- Where
- Boston
- Age
- 50 years and over
- People
- 50
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06001814 - No phaseTaking peopleBringing Medicines for HIV Prevention to a Family Planning Clinic
- Where
- Providence
- Age
- 16 years and over
- People
- 83
- Run by
- Women and Infants Hospital of Rhode Island
See details and how to joinNCT06930508 - No phaseNot yet taking people in United StatesA Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
- Where
- Chicago, Los Angeles, New York
- Age
- 18 years and over
- People
- 398
- Run by
- NYU Langone Health
See details and how to joinNCT07409350 - Phase 3Taking peopleA Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- Where
- Austin, Bakersfield, Baltimore, Chicago, Columbus, Dallas, Decatur, DeLand, El Paso, Fort Lauderdale, Ft. Pierce, Greensboro, Grosse Pointe Woods, Houston, Jacksonville, Kansas City, Las Vegas, Los Angeles, Lynchburg, Memphis, Miami, Newark, New Haven, Orlando, Pensacola, Philadelphia, Phoenix, Pittsburgh, Salt Lake City, San Diego, Santa Fe, Seattle, Stony Brook, Syracuse, Vero Beach, Washington D.C., West Hollywood, West Palm Beach, Winston-Salem
- Age
- 12 years and over
- People
- 564 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00 - No phaseNot yet taking people in United StatesDecentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV
- Where
- Long Island City, Philadelphia
- Age
- 18 years and over
- People
- 420
- Run by
- Montefiore Medical Center
See details and how to joinNCT07927673 - Phase 1/2Taking peopleTrial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 265
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05470491 - Phase 1/2Taking peopleSafety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
- Where
- Bethesda
- Age
- 18 years and over
- People
- 225
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05580458 - No phaseTaking peoplePeer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
- Where
- Baltimore, Washington D.C.
- Age
- 18 years to 88 years
- People
- 186
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT06501781 - No phaseTaking peopleOptimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
- Where
- Boise, Minneapolis, Seattle
- Age
- 18 years and over
- People
- 480
- Run by
- Seattle Institute for Biomedical and Clinical Research
See details and how to joinNCT07507435 - Phase 2Taking peoplePsilocybin Therapy for Methamphetamine Use Disorder and HIV
- Where
- San Francisco
- Age
- 25 years to 64 years
- People
- 30
- Run by
- Nicky Mehtani, MD, MPH
See details and how to joinNCT07756736 - Phase 4Not yet taking people in United StatesNOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings
- Where
- Durham
- Age
- 18 years and over
- People
- 450
- Run by
- Duke University
See details and how to joinNCT06854029 - No phaseNot yet taking people in United StatesPrescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 536
- Run by
- University of Pittsburgh
See details and how to joinNCT07073924 - No phaseEnrolling by invitationPromoting Aging and Thriving With HIV
- Where
- Indianapolis
- Age
- 50 years and over
- People
- 60
- Run by
- Indiana University
See details and how to joinNCT07192419